(Q36807472)

16 August 2017

1 reference

title

Therapy insight: guidelines for selection of contraception in women with rheumatic diseases (English)

1 reference

16 August 2017

1 reference

Lisa R Sammaritano

1

1 reference

16 August 2017

publication date

1 May 2007

1 reference

Nature Clinical Practice Rheumatology

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

273-81; quiz 305-6

1 reference

Recovery of bone density in women who stop using medroxyprogesterone acetate

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

Interactions with oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

Beyond the pill: new data and options in hormonal and intrauterine contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Hormonal contraception: recent advances and controversies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Safety concerns and health benefits associated with oral contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptives, thrombosis and haemostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptives and venous thromboembolism: a five-year national case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Mesenteric vein thrombosis associated with intravaginal contraceptives: a case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptives and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Contraceptives and cerebral thrombosis: a five-year national case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Stroke in users of low-dose oral contraceptives

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Combined oral contraceptives in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

A trial of contraceptive methods in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Alterations of estrogen metabolism in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptives and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Contraception with progestagens in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Exogenous sex hormones and the risk of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Oral contraceptive efficacy and antibiotic interaction: a myth debunked

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0484

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0484

1 reference

16 August 2017

1 reference